Australian medtech industry to issue revised code of conduct in 2012
This article was originally published in RAJ Devices
The Medical Technology Association of Australia is seeking feedback from stakeholders as it undertakes a review of its voluntary code of practice on interaction with healthcare professionals1. The MTAA review will lead to a revised edition of the code for member companies in 2012.
You may also be interested in...
An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.
EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.
The UK Medicines and Healthcare products Regulatory Agency wants clinical trial sponsors to integrate available regulatory flexibilities into normal practice so that their studies can withstand further potential disruptions from the COVID-19 pandemic.